JenniferL(Taylor)Taylor-CousarMD

PubMed

• Disparities in elexacaftor/tezacaftor/ivacaftor initiation in the US cystic fibrosis population.
  Timothy Vigers, Scott D Sagel, Kamyron Jordan, Jennifer L Taylor-Cousar> ;Pediatric Pulmonology. 2024 May 2
• Two-Year Impact of Highly Effective Modulator Therapy on Olfactory Dysfunction.
  Eugene Oh, Aastha Khatiwada, Stephen M Humphries, Alexandra Wilson, Eszter K Vladar, Jessa E Miller, David A Lynch, Jennifer L Taylor-Cousar, Daniel M Beswick> ;The Laryngoscope. 2024 Apr 22
• 1 citations
  Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.
  Theodore G Liou, Natalia Argel, Fadi Asfour, Perry S Brown, Barbara A Chatfield, David R Cox, Cori L Daines, Dixie Durham, Jessica A Francis, Barbara Glover, My Helms,...> ;Iscience. 2024 Mar 15
• Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis.
  Shijing Jia, Yizhuo Wang, Melissa H Ross, Jonathan B Zuckerman, Susan Murray, MeiLan K Han, Shannon E Cahalan, Blair E Lenhan, Ryan N Best, Jennifer L Taylor-Cousar, R...> ;Journal of Cystic Fibrosis. 2024 Mar 14
• 1 citations
  Prioritizing sexual and reproductive health research and care for people with cystic fibrosis: A 2023 workshop report from the Cystic Fibrosis Foundation Sexual Health...
  Traci M Kazmerski, Christie Moy, Enid Aliaj, Jessica Hudson, Brandon Wright, Maddie Poranski, Jacqui Sjoberg, Jennifer L Taylor-Cousar, Anna M Georgiopoulos, Sigrid L ...> ;Journal of Cystic Fibrosis. 2024 Mar 13
• Patient perspectives on chronic rhinosinusitis in cystic fibrosis: Symptom prioritization in the era of highly effective modulator therapy.
  Liu, C., Han, E., Fischer, J., Mace, J., Mattos, J., Markarian, K., Alt, J., Bodner, T., Chowdhury, N., Eshaghian, P., Getz, A., Hwang, P., Khanwalkar, A., Kimple, A.,...> ;International Forum of Allergy & Rhinology. 2024 Feb 11
• Chronic rhinosinusitis and olfaction after highly effective modulator therapy: The role of individual sinus inflammation.
  Jessa E Miller, Jennifer L Taylor-Cousar, Stephen M Humphries, Aastha Khatiwada, Haidee Chen, Alexandra Wilson, Eszter K Vladar, David A Lynch, Douglas A Li, Daniel M ...> ;International Forum of Allergy & Rhinology. 2024 May 1
• Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improve...
  Miller, J., Taylor-Cousar, J., Overdevest, J., Khatiwada, A., Mace, J., Alt, J., Bodner, T., Chowdhury, N., DiMango, E., Eshaghian, P., Getz, A., Gudis, D., Han, E., H...> ;International Forum of Allergy & Rhinology. 2023 Dec 25
• 3 citations
  Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least oneallele: 144-week interim results from a 192-week open-...
  Cori L Daines, Elizabeth Tullis, Stefano Costa, Rachel W Linnemann, Marcus A Mall, Edward F McKone, Deepika Polineni, Bradley S Quon, Felix C Ringshausen, Steven M Row...> ;The European Respiratory Journal. 2023 Dec 1
• Factors associated with pubertal growth outcomes in cystic fibrosis: Early Growth and Puberty in CF.
  Amalia S Magaret, Raksha Jain, Jennifer Taylor-Cousar, Kara S Hughan, Traci M Kazmerski, Patil, R.> ;Journal of Cystic Fibrosis. 2023 Nov 17
• Olfactory loss in people with cystic fibrosis: Community perceptions and impact.
  Jessa E Miller, Christine M Liu, Edith T Zemanick, Jason C Woods, Christopher H Goss, Jennifer L Taylor-Cousar, Daniel M Beswick> ;Journal of Cystic Fibrosis. 2023 Nov 17
• Decreases in Rhinology Care Utilization by People with Cystic Fibrosis on Highly Effective Modulator Therapy.
  Ethan J Han, Daniel M Beswick, Patricia H Eshaghian, Grant A Turner, Jivianne T Lee, Douglas A Li, Marilene B Wang, Jennifer L Taylor-Cousar, Jeffrey D Suh> ;The Annals of Otology, Rhinology, and Laryngology. 2024 Mar 1
• 2 citations
  Clinician perspectives and practices related to sexual and reproductive care provision for males with cystic fibrosis.
  Traci M Kazmerski, Olivia M Stransky, Danielle R Lavage, Kara S Hughan, Raksha Jain, Sigrid L Ladores, Michael S Stalvey, Vin Tangpricha, Jennifer L Taylor-Cousar, Nat...> ;Journal of Cystic Fibrosis. 2023 Nov 10
• 2 citations
  A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy.
  Jennifer L Taylor-Cousar, Rachel Janney, Peter G Middleton, Raksha Jain, Julia Nightingale, Natalie E West, Michal Shteinberg, Danielle Velez, Traci M Kazmerski> ;Journal of Cystic Fibrosis. 2023 Nov 10
• The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis.
  Raksha Jain, Traci M Kazmerski, Jennifer L Taylor-Cousar> ;Current Opinion in Pulmonary Medicine. 2023 Nov 1
• 2 citations
  Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.
  Bonnie Ramsey, Christoph U Correll, David R DeMaso, Edward McKone, Elizabeth Tullis, Jennifer L Taylor-Cousar, Chenghao Chu, Nataliya Volkova, Neil Ahluwalia, David Wa...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Feb 1
• 3 citations
  Impact of highly effective modulator therapy on chronic rhinosinusitis and health status: 2-year follow-up.
  Daniel M Beswick, Aastha Khatiwada, Jessa E Miller, Stephen M Humphries, Alexandra Wilson, Eszter K Vladar, David A Lynch, Jennifer L Taylor-Cousar> ;Journal of Cystic Fibrosis. 2023 Oct 5
• 9 citations
  Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.
  Nicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, Scott H Donaldson, Isabelle Fajac, Christopher H Goss, Deepika Polineni, Felix Ratjen, Bradley S Quon, Edith T Ze...> ;The Lancet. Respiratory Medicine. 2023 Oct 1
• 2 citations
  Factors that predict pursuing sinus surgery in the era of highly effective modulator therapy.
  Daniel M Beswick, Ethan J Han, Jess C Mace, Karolin Markarian, Jeremiah A Alt, Todd E Bodner, Naweed I Chowdhury, Patricia H Eshaghian, Anne E Getz, Peter H Hwang, Ash...> ;International Forum of Allergy & Rhinology. 2024 Apr 1
• Genetic therapies in cystic fibrosis.
  Jennifer L Taylor-Cousar, A Christopher Boyd, Eric W F W Alton, Deepika Polineni> ;Current Opinion in Pulmonary Medicine. 2023 Nov 1
• 12 citations
  CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis.
  Jennifer L Taylor-Cousar, Paul D Robinson, Michal Shteinberg, Damian G Downey> ;Lancet. 2023 Sep 30
• Traits, trends and hits of orphan drug designations in cystic fibrosis.
  Enrico Costa, Silvia Girotti, Hendrika A van den Ham, Marco Cipolli, Cornelis K van der Ent, Jennifer L Taylor-Cousar, Hubert G M Leufkens> ;Journal of Cystic Fibrosis. 2023 Sep 1
• 5 citations
  Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis.
  Giselle Peng, Jennifer L Taylor-Cousar, MinJae Lee, Ashley Keller, Natalie E West, Traci M Kazmerski, Jennifer L Goralski, Moira L Aitken, Andrea H Roe, Denis Hadjilia...> ;Journal of Cystic Fibrosis. 2023 Sep 1
• 27 citations
  Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least OneAllele.
  Jennifer L Goralski, Jordana E Hoppe, Marcus A Mall, Susanna A McColley, Edward McKone, Bonnie Ramsey, Jonathan H Rayment, Phil Robinson, Florian Stehling, Jennifer L ...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Jul 1
• 6 citations
  Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy.
  Kamyron D Jordan, Edith T Zemanick, Jennifer L Taylor-Cousar, Jordana E Hoppe> ;Expert Review of Respiratory Medicine. 2023 Feb 1
• Join now to see all

Journal Articles

• Effect of Ivacaftor in patients with cystic fibrosis, and a G551D-CFTR mutation: expanded acces program in the United States  
  Taylor-Cousar JL, Nikknian M, Gilmartin G and Pilewski J, J Cyst Fibros, 1/11/2015
• Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis  
  Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D, Sagel SD, Khan U, Mayer-Hamblett N, Van Dalfsen JM, Joseloff E, Ramsey BW; GOAL Investigators of th..., Am J Respir Crit Care Med, 1/15/2014
• Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)  
  McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC; VX08-770-105 (PE..., Lancet Respir Med, 1/1/2014
• A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacafor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised...  
  Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR and Rodman D; VX09-809-102 Study Group, Lancet Respir Med, 1/1/2014
• Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection  
  Clancy JP, Dupont L, Konstan MW, Billings J, Fustik S, Goss CH, Lymp J, Minic P, Quittner AL, Rubenstein RC, Young KR, Saiman L, Burns JL, Govan JR,Ramsey B, Gupta R; ..., Thorax, 1/1/2013
• Genetic modifiers of liver disease in cystic fibrosis  
  Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M J..., JAMA, 1/9/2009
• A Critical Care Perpective on Immunotherapy in Lung Transplantation  
  Taylor JL and Palmer SM, J Intensive Care Med, 1/1/2006
• Mycobacterial Abscessus Chest Wall and Pulmonary Infection in a Cystic Fibrosis Lung Transplant Recipient  
  Taylor JL and Palmer SM, J Heart Lung Transplant, 1/1/2006
• HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania  
  Ole-Nguyaine S, Crump JA, Kibiki GS, Kiang K, Taylor J, Schimana W, et al, Ann Trop Med Parasitol, 1/1/2004
• Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury  
  Taylor JL, Carraway MS, Piantadosi CA, Am J Physiol, 1/1/1998
• Induction of ferritin and heme oxygenase-1 by endotoxin in the lung  
  Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA, Am J Physiol, 1/1/1998
• Lumacaftor–ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR  
  Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A,..., N Engl J Med
• Join now to see all

Abstracts/Posters

• The Pharmacokinetics of N91115, An Inhibior of S Nitrosoglutathione Reductase in Cystic Fibrosis Patients
  Solomon G, Zemanick E, Taylor-Cousar, JL, Pediatr Pulmonol Suppl, 1/1/2015
• Use of clofazimine in difficult to treat nontuberculous mycobacterial infections
  Martiniano S, Sagel, S, Zemanick, E, DeVoogd, R, Accurso, F, Nick, J, Saavedra, M, Nichols, D, Taylor-Cousar, J, Levin, A, Czaja, C, Huitt, G, Kasperbauer, S, Daley, C, Pediatr Pulmonol Suppl, 1/1/2014
• Correlation of a semi-quantitative lung magnetic resonance imaging score with baseline lung function in Cystic Fibrosis
  Taylor-Cousar JL, Jin GY, Nambu A, Bieder J, Newell JD, Chung J, St. Clair C, Jones M, Puderbach M, Nichols DP, Saavedra MT, Schroeder J and Nick JA, NACFC, 1/1/2011
• Enhanced voriconazole absorption in a cystic fibrosis patient with concomitant administration of pancreatic enzymes
  Casciano M, Barber G, Taylor-Cousar JL, 1/1/2011
• Correlation of magnetic resonance imaging score with lung function in Cystic Fibrosis
  Taylor-Cousar JL, Biederer J, Puderbach M , Jin GY, Nambu A, Newell JD, Chung J, Schroeder J, St. Clair C, Jones M, Saavedra MT, Nichols DP and Nick JA, ATS, 1/1/2011
• Endobronchial instillation of Tobi following bronchoscopy during bronchoalveolar lavage (BAL) in two cystic fibrosis (CF) patients results in measurable serum concentr...
  Amarante M and Taylor JL, Pediatric Pharmacy Conference, 1/1/2006
• Join now to see all

Lectures

• Update in Cystic Fibrosis 
  Phoenix, AZ - 1/1/2016
• Adult Issues in Cystic Fibrosis 
  1/1/2016
• CF Airway Inflammation, Biomarkers & Therapeutic Targets 
  1/1/2015
• Cystic Fibrosis Clinical Care and Research 
  Denver, CO - 1/1/2015
• Cystic Fibrosis Therapeutics: Great Strides and Future Directions 
  Durham, NC - 1/1/2015
• Cystic Fibrosis and Lung Transplant: A Discussion with a Physician and a Transplant Recipient 
  1/1/2015
• Ivacaftor in Advanced CF Lung Disease 
  1/1/2015
• Introduction to Cystic Fibrosis 
  1/1/2015
• Update on Clinical Trials and Novel Therapy in CF 
  1/1/2015
• CF Update: CFTR Directed Therapies 
  Keystone, CO - 1/1/2015
• Cystic Fibrosis Cases 
  Keystone, CO - 1/1/2015
• Genetic and phenotypic characterization of chronic airway disease in non-human primates 
  1/1/2014
• The Evaluation of the Adult with Bronchiectasis: Could This be CF 
  1/1/2014
• Diagnosis and Evaluation of Adults with CF 
  1/1/2014
• Cardiovascular Disease in Adults with CF 
  1/1/2014
• Upper and Lower Airway Disease in Human and Non-Human Primates 
  Wauchula, FL - 1/1/2014
• Oral Sildenafil Reduces Airway Inflammation in Adults With Cystic Fibrosis 
  1/1/2013
• Lung Transplant and Non-Pulmonary Complications in Cystic Fibrosis 
  1/1/2013
• Transplant: Things a Person with CF Should Know 
  1/1/2013
• Oral Sildenafil Reduces Airway Inflammation in Adults with CF 
  1/1/2013
• Summary of CF Clinical and Translational Research at NJH 
  1/1/2013
• Lung MRI Imaging in CF: A New Outcome Measure for Clinical Care and Clinical Research 
  1/1/2012
• CF Clinical Research: Challenges and Updates 
  1/1/2012
• Cystic Fibrosis Advanced Disease State Training 
  1/1/2012
• Lung MRI Imaging in CF: A New Outcome Measure for Clinical Care and Clinical Research? 
  1/1/2011
• Join now to see all

Other

• ATS Policy Brief on the Pulmonary, Critical Care and Sleep Workforce 
  Taylor-Cousar JL
  http://www.thoracic.org/advocacy/policy-position-statements/index.php
  1/1/2012
• Patient Perspective on Lung Transplant 
  Taylor-Cousar JL, Cystic Fibrosis Foundation Webcast
  http://media.newsinfusion.com/LungTransplantation/
  1/1/2011